Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Fibrillation Prior and Post Elective Cardioversion

NCT05926401 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05926401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Fibrillation Prior and Post Elective Cardioversion
Lead sponsor
Sorlandet Hospital HF
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
December 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.